We concluded that Akt activation in Pten-deficient prostate cancer cells could not protect against oxidative stress-induced cell death, but rather sensitized the cells to ROS-induced cell death by increasing their intracellular ROS levels. This evidence concerns the gene AKT1 and Familial prostate cancer.